Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2015
16th World Conference on Lung Cancer
Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado
Presentation Date(s):- September 6 - 9, 2015
- Total Presentations: 2499
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
-
+
JCHS - Joint IASLC - Chinese Society for Clinical Oncology - Chinese Alliance Against Lung Cancer Session
- Type: Joint Chinese/ English Session
- Track: Other
- Presentations: 14
- Moderators:C. Bai
- Coordinates: 9/06/2015, 07:30 - 10:30, Mile High Ballroom 1a-1f
-
+
JCHS.04 - Current Status of Molecular Testing in China: Application and Technology
08:15 - 08:35 | Author(s): S. Lu
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P1.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 87
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.01-023 - Discrepancy of ALK Status in Lung Adenocarcinoma Subtypes According to the IALSC/ATS/ERS Classification in Chinese Patients
09:30 - 09:30 | Author(s): S. Lu
- Abstract
Loading...
-
+
ORAL 04 - Adjuvant Therapy for Early Stage Lung Cancer
- Type: Oral Session
- Track: Treatment of Localized Disease - NSCLC
- Presentations: 8
- Moderators:E. Vallieres
- Coordinates: 9/07/2015, 10:45 - 12:15, 205+207
-
+
ORAL04.02 - Research of Vascular Targeted Therapy in the Postoperative Adjuvant Chemotherapy for Lung Cancer
10:56 - 11:07 | Author(s): Z. Chen
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MINI 08 - Prognostic/Predictive Biomarkers
- Type: Mini Oral
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 15
- Moderators:T.E. Stinchcombe
- Coordinates: 9/07/2015, 16:45 - 18:15, Mile High Ballroom 4a-4f
-
+
MINI08.05 - A Survival Comparison Study of Chinese Patients with Primary Lung Adenocarcinoma Harboring ALK Rearrangements Detected in Different Methods with Crizotinib Treatment
17:15 - 17:20 | Author(s): S. Lu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 102
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.01-024 - An ENSURE Extension Study to Evaluate 2nd Line Erlotinib and Gemcitabine/Cisplatin Cross-Over Treatment for EGFR-Mutant Chinese NSCLC Patients
09:30 - 09:30 | Author(s): Y. Wu
- Abstract
Loading... -
+
P2.01-066 - A Prospective, Randomized, Multicenter, Phase III Study, Comparing rhTPO with rhIL-11 Treating CIT - An Interim Analysis (NCT02344979)
09:30 - 09:30 | Author(s): S. Lu
- Abstract
Loading...
-
+
P2.03 - Poster Session/ Treatment of Locoregional Disease – NSCLC
- Type: Poster
- Track: Treatment of Locoregional Disease – NSCLC
- Presentations: 38
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.03-031 - Subgroup Analysis of East Asian Patients in the Phase III PROCLAIM Trial
09:30 - 09:30 | Author(s): L.(. Wang
- Abstract
Loading...
-
+
P3.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 91
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.01-006 - Propensity Score Matched Comparison of EGFR TKI for EGFR Mutation 19del vs 21L858R
09:30 - 09:30 | Author(s): Z. Zhou
- Abstract
Loading... -
+
P3.01-010 - Multivariate Survival Analysis of China IRESSA Charitable Aid Project in Shanghai
09:30 - 09:30 | Author(s): H. Jian
- Abstract
Loading... -
+
P3.01-050 - A Interim Analysis of Randomized Phase III Trial of Nedaplatin or Cisplatin Combined with Docetaxel as First-Line Treatment for Advanced ASQC
09:30 - 09:30 | Author(s): S. Lu
- Abstract
Loading...
-
+
P3.03 - Poster Session/ Treatment of Locoregional Disease – NSCLC
- Type: Poster
- Track: Treatment of Locoregional Disease – NSCLC
- Presentations: 38
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.03-017 - Interim Overall Survival of Neoadjuvant Erlotinib Intercalated with Gemcitabine/Cisplatin for IIIA N2 NSCLC Patients: A Phase II Study
09:30 - 09:30 | Author(s): Z. Chen
- Abstract
Loading...
-
+
P3.08 - Poster Session/ Thymoma, Mesothelioma and Other Thoracic Malignancies
- Type: Poster
- Track: Thymoma, Mesothelioma and Other Thoracic Malignancies
- Presentations: 38
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.08-025 - Clinical and Radiographic Manifestation of PPNHL in Chinese Patients: Differentiation of MALT Type and DLBCL Type
09:30 - 09:30 | Author(s): Y. Yao
- Abstract
Loading...
-
+
ORAL 32 - EGFR WT and MT Targeting
- Type: Oral Session
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 8
- Moderators:K.J. O'Byrne
- Coordinates: 9/09/2015, 16:45 - 18:15, Four Seasons Ballroom F3+F4
-
+
ORAL32.01 - Tumor Genomic Analysis from LUX-Lung 8: A Phase III Trial of Afatinib versus Erlotinib in Squamous Cell Carcinoma of the Lung
16:45 - 16:56 | Author(s): J. Soria
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ORAL32.06 - Intercalating and Maintenance Use of Gefitinib plus Chemotherapy versus Chemotherapy Alone in Selected Advanced NSCLC: A Phase III Study
17:39 - 17:50 | Author(s): H. Jian
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.